Cargando…
Acute Psychosis in COVID-19: Is It Due to Favipiravir Treatment or Acute Viral Illness?
In this report, we present a case of acute psychosis that occurred after the loading dose of favipiravir, one of the most prescribed antiviral drugs in many countries, in a patient with COVID-19. A 31-year-old female was readmitted to the emergency department after 3 days of sleep disturbance, inter...
Autores principales: | Duyan, Murat, Ozturan, Ibrahim Ulas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106544/ https://www.ncbi.nlm.nih.gov/pubmed/33997622 http://dx.doi.org/10.1007/s42399-021-00952-x |
Ejemplares similares
-
Delayed Parosmia Following SARS-CoV-2 Infection: a Rare Late Complication of COVID-19
por: Duyan, Murat, et al.
Publicado: (2021) -
rRT-PCR Results of a Covid-19 Diagnosed Geriatric Patient
por: Görgülü, Özkan, et al.
Publicado: (2020) -
Effects of Comorbid Factors on Prognosis of Three Different Geriatric Groups with COVID-19 Diagnosis
por: Görgülü, Özkan, et al.
Publicado: (2020) -
Tocilizumab, Remdesivir, Favipiravir, and Dexamethasone Repurposed for COVID-19: a Comprehensive Clinical and Pharmacovigilant Reassessment
por: Kelleni, Mina T.
Publicado: (2021) -
Pulmonary Embolism and Acute Psychosis, a Case Report of an Outpatient with a Mild Course of COVID-19
por: Makivic, Nina, et al.
Publicado: (2021)